Abstract:RNA-guided and RNA-targeting type IV-D CRISPR/Cas systems (CRISPR/Cas13d) have recently been identified and employed for efficient and specific RNA knockdown in mammalian and plant cells. Cas13d possesses dual RNase activities and is capable of processing CRISPR arrays and cleaving target RNAs in a protospacer flanking sequence (PFS)-independent manner. These properties make this system a promising tool for multiplex gene expression regulation in microbes. Herein, we aimed to establish a CRISPR/Cas13d-mediated RNA knockdown platform for bacterial chassis. CasRx, Cas13d from Ruminococcus flavefaciens XPD3002, was selected due to its high activity. However, CasRx was found to be highly toxic to both Escherichia coli and Corynebacterium glutamicum, especially when it cooperated with its guide and target RNAs. After employing a low copy number vector, a tightly controlled promoter, and a weakened ribosome binding site, we successfully constructed an inducible expression system for CasRx and applied it for repressing the expression of a green fluorescent protein (GFP) in E. coli. Despite our efforts to optimize inducer usage, guide RNA (gRNA) architecture and combination, and target gene expression level, the highest gene repression efficiency was 30–50% at the protein level and ∼70% at the mRNA level. The moderate RNA knockdown is possibly caused by the collateral cleavage activity toward bystander RNAs, which acts as a mechanism of type IV-D immunity and perturbs microbial metabolism. Further studies on cellular response to CRISPR/Cas13d and improvement in RNA knockdown efficiency are required prior to practical application of this system in microbes.

Collateral Activity of the CRISPR/RfxCas13d System in Human Cells.

The Collateral Activity of RfxCas13d Can Induce Lethality in a RfxCas13d Knock-in Mouse Model

RNA-guided cell targeting with CRISPR/RfxCas13d collateral activity in human cells

Collateral cleavage of 28s rRNA by RfxCas13d causes death of mice

Low copy CRISPR-Cas13d mitigates collateral RNA cleavage

High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster Using CRISPR/CasRx

The CRISPR-Cas13a Gene-Editing System Induces Collateral Cleavage of RNA in Glioma Cells.

CRISPR/Cas13d-Mediated Microbial RNA Knockdown

Collateral Effects: The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells (Adv. Sci. 20/2019)

Shotgun Knockdown of RNA by CRISPR-Cas13d in Fission Yeast.

Optimizing a CRISPR-Cas13d Gene Circuit for Tunable Target RNA Downregulation with Minimal Collateral RNA Cutting

Intrinsic RNA Targeting Constrains the Utility of CRISPR-Cas13 Systems

Engineered CRISPR RNA improves the RNA cleavage efficiency of hfCas13X

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish

Precise transcript targeting by CRISPR-Csm complexes

Intrinsic RNA-targeting activity limits the applicability of CRISPR-Cas13

Intrinsic targeting of host RNA by Cas13 constrains its utility

Cytosolic CRISPR RNA for RNA-targeting CRISPR-Cas systems

Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors

Programmable RNA targeting with the single-protein CRISPR effector Cas7-11